Efficacy [qlco]    
Safety [hcpp]    
Survival [acty]    
treatment [ftcn]    
-- Japanese [popg]    
Patients [podg]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Oral [spco]    
Inhibitor [qlco]    
Approved [qlco]    
treatment [ftcn]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Evaluated [hlca]    
Safety [hcpp]    
Effectiveness [qlco]    
-- Japanese [popg]    
Patients [podg]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Aims [idcn]    
Purpose [ftcn]    
Study [mnob]    
Efficacy [qlco]    
Safety [hcpp]    
Risk Factors [qnco]    
Survival [acty]    
Patients [podg]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Treated [ftcn]    
Methods [inpr]    
May [tmco]    
December [qlco]    
-- Japanese [popg]    
Patients [podg]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
MALE [orga]    
FEMALE [orga]    
YEARS [tmco]    
Treated [ftcn]    
Eighty [qnco]    
Eight [qnco]    
Patients [podg]    
Child-Pugh [inpr]    
Class [inpr]    
Patients [podg]    
Child-Pugh Class B [inpr]    
LIVER CIRRHOSIS [dsyn]    
Liver Cancer [neop]    
Stage B [inpr]    
Patients [podg]    
Twelve [qnco]    
Patients [podg]    
Partial Response [fndg]    
therapy [ftcn]    
Patients [podg]    
Stable Disease [fndg]    
Patients [podg]    
progressive disease [neop]    
First assessment [fndg]    
Radiologic [bmod]    
adverse events [patf]    
Leading [tmco]    
Discontinuation [hlca]    
treatment [ftcn]    
Dysfunction, Liver [patf]    
Hand Skin [bpoc]    
FOOT [bpoc]    
Reaction [ftcn]    
DIARRHOEA [sosy]    
Median Survival Time [tmco]    
TIME [tmco]    
Progression [patf]    
3 Months [tmco]    
des(gamma-carboxy)prothrombin [aapp]    
SERUM [bdsu]    
Levels [qlco]    
Duration [tmco]    
treatment [ftcn]    
Identified [qlco]    
Independent [idcn]    
Risk Factors [qnco]    
Survival [acty]    
Conclusions [idcn]    
Study [mnob]    
Useful [qlco]    
-- Japanese [popg]    
Patients [podg]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Addition [ftcn]    
Study [mnob]    
Administered [ftcn]    
long-term treatment [hlca]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Therapeutic Effect [clna]    
Dosage [qnco]    
Copyright [inpr]    
AG [geoa]    
Basel [hcro]    
